Anticancer Research | Special Issue 2025
Ovarian Cancer Immunology and Immunotherapy– 2026
1. TOPICS:
● T Cells and Tumor-Infiltrating Lymphocytes (TILs):
o CD8⁺ cytotoxic T cells
o CD4⁺ T cells
o Progenitor stem-like memory T cells
o Clonally expanded T cells and T-cell receptors
● Antigen-Presentation and HLA associations:
o Antigen-presenting cells (dendritic cells and others)
o HLA associations
● Tumor Antigens:
o Tumor-associated antigens
o Tumor-specific antigens. Neoantigens. TP53, RAS
● Tumor Genetics and Variants:
o Genetic and somatic variations of tumor cells
● B cells and Autoantibodies. Cytokines.
● Natural Killer (NK) Cells and Innate Immunity.
● Tumor Microenvironment.
● Immunosuppression:
o Immunosuppressive cells: Tregs, myeloid-derived suppressor cells, tumor-associated macrophages
o Immunosuppressive molecules (IL-10, TGF-β, others)
● Single-cell analysis studies.
● Checkpoint Inhibitors and Immune Modulation:
o PD-1, PD-L1, and other checkpoints
● Immunotherapy Approaches:
o Adoptive cell therapies (TILs, CARs)
o Immune response modulators
o Animal models of ovarian cancer
2. Deadline for article(s) submission: February 5, 2026.
3. The special issue is scheduled for publication in April 2026.
4. Manuscripts (reviews and original experimental or clinical research articles) should follow the Instructions for Authors of Anticancer Research and should be submitted for publication through our new online submission system: www.iiar-
In Vivo | Special Issue 2025
Diabetes: New Antidiabetic Agents; Stem Cell Therapy; Pancreas Transplantation – 2025
1. TOPICS: A. New Antidiabetic Agents
1. Development of novel antidiabetic drugs
2. Overcoming drug resistance
3. Combination therapies
4. Oncolytic viruses
B. Stem Cell Therapy in Diabetes
1. Stem cell-based regenerative therapies
2. Stem cell-derived pancreatic cells
3. Overcoming immune rejection in stem cell therapy
C. Pancreas Transplantation
1. Advances in pancreas transplant techniques
2. Pancreatic islet transplantation
3. Immunosuppression in pancreas transplantation
2. Deadline for article(s) submission: September 30, 2025.
3. The instructions to Authors of ΙN VIVO apply to this special issue, in the same way they apply to any ΙN VIVO issue.
4. Upon acceptance, Authors will be asked to pay an online publication fee of USD 1,000 for articles up to 8 online pages (including figures and tables). Each additional excess page will be charged USD 60.00. Color will not be charged.
5. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
6. The special issue is scheduled for publication in January 2026.
7. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com